Search
+
    SEARCHED FOR:

    TENTATIVE APPROVAL

    Alembic Pharma gets tentative nod from USFDA for Ivosidenib tablets

    The company said Ivosidenib tablets are indicated for patients with newly diagnosed Acute Myeloid Leukemia (AML) as monotherapy in adults 75 years or older, or who have comorbidities that preclude the use of intensive induction chemotherapy.

    Zydus Lifesciences gets tentative approval from USFDA for BP lowering drug

    Zydus Lifesciences announced on Thursday that it has received tentative approval from the US Food and Drug Administration (USFDA) to market its generic Azilsartan Medoxomil tablets, which are used to treat high blood pressure. The USFDA's tentative approval covers Azilsartan Medoxomil tablets in strengths of 40 mg and 80 mg.

    Indoco Remedies gets USFDA nod to market generic diabetes drug

    Indoco Remedies on Thursday said it has received approval from the US health regulator to market a generic diabetes medication. The company has received tentative approval from the US Food and Drug Administration (USFDA) for abbreviated new drug application (ANDA) for Canagliflozin and Metformin Hydrochloride tablets in various strengths, Indoco Remedies said in a regulatory filing.

    RAW official linked to assassination plot of Khalistan separatist leader Gurpatwant Singh Pannun in US, approved by ex-chief: Report

    An investigative report reveals that a RAW official, Vikram Yadav, was involved in an assassination plot against Khalistan separatist leader Gurpatwant Singh Pannun in the US, approved by ex-chief Samant Goel. Pannun is a key figure in the Khalistan movement. The report, published by The Washington Post, indicates broader involvement of RAW officials. The Biden administration has refrained from making charges against Yadav, with Nikhil Gupta, an alleged middleman, facing charges of hiring a contract killer.

    Tesla soars 12% on tentative approval for driving system in China

    The developments came after Tesla Chief Executive Officer Elon Musk made an unannounced trip to China on Sunday, seeking approval for driver-assistance software that could help arrest the carmaker’s revenue decline. While the company’s suite of features require constant supervision and don’t make Teslas autonomous, the company charges $8,000 for them in the US, or $99 a month for a subscription.

    Alembic Pharma gets tentative USFDA nod for breast cancer drug

    The medicine is indicated for the treatment of adult patients with a certain type of advanced or metastatic breast cancer in a combination of drug therapy.

    The Economic Times
    BACK TO TOP